US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OCULIS HOLDING AG C/WTS 02/03/2028 (TO PUR ORD)

16.97

0.0000

Volume:2.00

Turnover:33.94

Market Cap:740.95M

PE:-6.23

High:16.97

Open:16.97

Low:16.97

Close:16.97

52wk High:17.50

52wk Low:3.37

Shares:43.66M

Float Shares:43.66M

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7247

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

OCULIS HOLDING AG C/WTS 02/03/2028 (TO PUR ORD)

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OCSAW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"OCSAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCSAW\",,,,,undefined,":{"symbol":"OCSAW","market":"US","secType":"STK","nameCN":"OCULIS HOLDING AG C/WTS 02/03/2028 (TO PUR ORD)","latestPrice":16.97,"timestamp":1771016400000,"preClose":16.97,"halted":0,"volume":2,"delay":0,"changeRate":0,"floatShares":43662401,"shares":43662401,"eps":-2.7247,"marketStatus":"Closed President's Day","change":0,"latestTime":"02-13 16:00:00 EST","open":16.97,"high":16.97,"low":16.97,"amount":33.9401,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.7247,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":16.97,"volumeRatio":0.0004439511673427354},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCSAW\",,,,,undefined,":{"symbol":"OCSAW","floatShares":43662401,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.0004439511673427354,"shares":43662401,"dividePrice":0,"high":16.97,"amplitude":0,"preClose":16.97,"low":16.97,"week52Low":3.37,"pbRate":"--","week52High":17.5,"institutionHeld":0,"latestPrice":16.97,"eps":-2.7247,"divideRate":0,"volume":2,"delay":0,"ttmEps":-2.7247,"open":16.97,"prevYearClose":8.56,"prevWeekClose":16.97,"prevMonthClose":16.8,"prevQuarterClose":8.56,"fiveDayClose":16.84,"twentyDayClose":12,"sixtyDayClose":8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCSAW\",params:#limit:5,,,undefined,":[{"date":"2025-08-21","symbol":"OCSAW","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755806400000,"name":null,"time":"Post Market","dateTimestamp":1755748800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCSAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OCSAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.4142},{"period":"3month","weight":1.0977},{"period":"6month","weight":1.4312},{"period":"1year","weight":0.7004},{"period":"ytd","weight":0.9825}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.865807},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.08506},{"month":3,"riseRate":0,"avgChangeRate":-0.066082},{"month":4,"riseRate":0.333333,"avgChangeRate":0.004163},{"month":5,"riseRate":0.666667,"avgChangeRate":0.337508},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055329},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.024335},{"month":8,"riseRate":0.666667,"avgChangeRate":0.185476},{"month":9,"riseRate":0.666667,"avgChangeRate":0.068088},{"month":10,"riseRate":0.666667,"avgChangeRate":0.584471},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.097547},{"month":12,"riseRate":1,"avgChangeRate":0.174585}],"exchange":"NASDAQ","name":"OCULIS HOLDING AG C/WTS 02/03/2028 (TO PUR ORD)","nameEN":"OCULIS HOLDING AG C/WTS 02/03/2028 (TO PUR ORD)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OCSAW\",market:\"US\",,,undefined,":null}}